We are live on ! Find out more
B

Bpifrance Portfolio holdings

AUM $1.65B
1-Year Est. Return 19.85%
This Fund
S&P 500
This Quarter Est. Return
+12.34%
1 Year Est. Return
-19.85%
3 Year Est. Return
-49.36%
5 Year Est. Return
-48.43%
10 Year Est. Return
–
AUM
$4.5B
AUM Growth
+$543M
Cap. Flow
+$42.2M
Cap. Flow %
0.94%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
VECT
VectivBio Holding AG Ordinary Shares
VECT
+$42.6M

Top Sells

Rank Stock Value
1
CRSP icon
CRISPR Therapeutics
CRSP
+$389K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 84.11%
2 Materials 6.9%
3 Energy 4.93%
4 Communication Services 2.73%
5 Healthcare 0.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STLA icon
1
Stellantis
STLA
$16.7B
$3.79B 84.11%
192,703,907
– –
CSTM icon
2
Constellium
CSTM
$3.78B
$311M 6.9%
16,393,903
– –
FTI icon
3
TechnipFMC
FTI
$28.7B
$222M 4.93%
24,688,691
– –
CRTO icon
4
Criteo
CRTO
$1.11B
$123M 2.73%
2,718,752
– –
VECT
5
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$32.7M 0.73%
+2,806,217
New +$42.6M
SQNS
6
Sequans Communications SA
SQNS
$40.7M
$19.9M 0.44%
132,001
– –
CLLS
7
Cellectis
CLLS
$262M
$6.59M 0.15%
425,726
– –
CRSP icon
8
CRISPR Therapeutics
CRSP
$4.63B
$777K 0.02%
4,800
-3,200
-40% -$389K

Similar funds

CCM
Compass Capital Management Minneapolis, Minnesota $1.66B AUM 7.83% 1-Year Est. Return
BFPW
BOK Financial Private Wealth Denver, Colorado $1.66B AUM 18.56% 1-Year Est. Return
PP
Patten & Patten Chattanooga, Tennessee $1.66B AUM 18.12% 1-Year Est. Return
ACM
Anomaly Capital Management New York $1.65B AUM 26.47% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.65B AUM 20.56% 1-Year Est. Return
RIA
Recurrent Investment Advisors Houston, Texas $1.66B AUM 38.27% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
ELI
Empire Life Investments Toronto, Ontario, Canada $1.65B AUM 29.46% 1-Year Est. Return

Bpifrance's Q2 2021 Portfolio in Review

As of Q2 2021, Bpifrance held 8 positions worth $4.5B, up 14% from $3.96B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Bpifrance's Q2 2021 filing shows 1 new and 1 reduced positions. Its largest new stake was VectivBio Holding AG Ordinary Shares: 2,806,217 shares worth $32.7M. The largest sale was CRISPR Therapeutics, an estimated $389K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 84% of assets, down from 86% a quarter earlier, followed by Materials and Energy.

  • Bpifrance's largest Q2 2021 buy was VectivBio Holding AG Ordinary Shares: 2,806,217 shares worth $32.7M.
  • Bpifrance's biggest Q2 2021 reduction was CRISPR Therapeutics, cutting an estimated $389K.
  • Bpifrance's ten largest holdings make up 100% of its $4.5B portfolio in Q2 2021.
  • Bpifrance opened 1 new position and closed 0 in Q2 2021.
  • Bpifrance's portfolio value rose 14% quarter-over-quarter to $4.5B.

Based on Bpifrance's 13F filing for Q2 2021, filed 30 Jul 2021.